AR207445A1 - Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas - Google Patents

Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas

Info

Publication number
AR207445A1
AR207445A1 AR253332A AR25333274A AR207445A1 AR 207445 A1 AR207445 A1 AR 207445A1 AR 253332 A AR253332 A AR 253332A AR 25333274 A AR25333274 A AR 25333274A AR 207445 A1 AR207445 A1 AR 207445A1
Authority
AR
Argentina
Prior art keywords
pirazolones
substituted
procedure
preparation
new derivatives
Prior art date
Application number
AR253332A
Other languages
English (en)
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2319279A external-priority patent/DE2319279A1/de
Priority claimed from DE2363138A external-priority patent/DE2363138A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AR207445A1 publication Critical patent/AR207445A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR253332A 1973-04-17 1974-01-01 Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas AR207445A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2319279A DE2319279A1 (de) 1973-04-17 1973-04-17 Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2363138A DE2363138A1 (de) 1973-12-19 1973-12-19 Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
AR207445A1 true AR207445A1 (es) 1976-10-08

Family

ID=25764995

Family Applications (2)

Application Number Title Priority Date Filing Date
AR253332A AR207445A1 (es) 1973-04-17 1974-01-01 Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas
AR258463A AR207242A1 (es) 1973-04-17 1975-01-01 Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR258463A AR207242A1 (es) 1973-04-17 1975-01-01 Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas

Country Status (21)

Country Link
US (1) US3952008A (it)
JP (1) JPS59512B2 (it)
AR (2) AR207445A1 (it)
BG (2) BG22394A3 (it)
CA (1) CA1048513A (it)
CH (2) CH603593A5 (it)
DD (1) DD113230A5 (it)
DK (1) DK136155C (it)
ES (2) ES425374A1 (it)
FR (1) FR2226171B1 (it)
GB (1) GB1424492A (it)
HK (1) HK55876A (it)
HU (1) HU168591B (it)
IE (1) IE39213B1 (it)
IL (1) IL44627A (it)
LU (1) LU69871A1 (it)
NL (1) NL7405116A (it)
NO (1) NO139439C (it)
PL (1) PL96880B1 (it)
RO (2) RO63750A (it)
SE (1) SE408552B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2319278C2 (de) * 1973-04-17 1986-02-20 Bayer Ag, 5090 Leverkusen Pharmazeutisches Mittel
USRE30420E (en) * 1973-04-17 1980-10-21 Bayer Aktiengesellschaft Pyrazol-5-ones
US4056533A (en) * 1973-04-17 1977-11-01 Bayer Aktiengesellschaft Pyrazol-5-ones
US4000294A (en) * 1973-04-17 1976-12-28 Bayer Aktiengesellschaft Pyrazol-5-ones
DE2427272C3 (de) * 1974-06-06 1981-10-01 Bayer Ag, 5090 Leverkusen 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
DE2526469A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5585571A (en) * 1978-12-22 1980-06-27 Nippon Synthetic Chem Ind Co Ltd:The Preparation of 1,3-disubstituted-5-pyrazolone
JPH0730031B2 (ja) * 1986-04-02 1995-04-05 日産化学工業株式会社 ２―ピラゾリン―５―オン類の製造法
WO2006094201A2 (en) * 2005-03-02 2006-09-08 La Jolla Pharmaceutical Company Semicarbazide-sensitive amide oxidase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
NL121416C (it) * 1961-05-31

Also Published As

Publication number Publication date
CA1048513A (en) 1979-02-13
ES425374A1 (es) 1976-09-16
DK136155C (da) 1978-01-30
IE39213B1 (en) 1978-08-30
CH603593A5 (it) 1978-08-31
NO139439C (no) 1979-03-14
AR207242A1 (es) 1976-09-22
IL44627A0 (en) 1974-06-30
FR2226171A1 (it) 1974-11-15
HK55876A (en) 1976-09-17
BG22394A3 (bg) 1977-02-20
FR2226171B1 (it) 1978-07-28
RO69408A (ro) 1980-06-15
JPS5012082A (it) 1975-02-07
RO63750A (ro) 1980-06-15
DK136155B (da) 1977-08-22
JPS59512B2 (ja) 1984-01-07
ES447081A1 (es) 1977-06-16
BG22820A3 (bg) 1977-04-20
IE39213L (en) 1974-10-17
US3952008A (en) 1976-04-20
NO741364L (no) 1974-10-18
DD113230A5 (it) 1975-05-20
LU69871A1 (it) 1974-11-21
GB1424492A (en) 1976-02-11
NO139439B (no) 1978-12-04
NL7405116A (it) 1974-10-21
CH605799A5 (it) 1978-10-13
IL44627A (en) 1978-07-31
HU168591B (it) 1976-06-28
AU6817574A (en) 1975-10-23
PL96880B1 (pl) 1978-01-31
SE408552B (sv) 1979-06-18

Similar Documents

Publication Publication Date Title
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
AR210725A1 (es) Procedimiento para la preparacion de derivados de dibenzoxepina
RO70474A (ro) PROCEDEU PENTRU PREPARAREA PARAXILENULёI
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
AR207242A1 (es) Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
AR203188A1 (es) Procedimiento para la preparacion de derivados de tienotriazolodiacepina
AR206610A1 (es) Procedimiento de preparacion de 2-metoxi-5-sulfonil(sustituidos)-benzamidas-(-sustituidas
TR17584A (tr) Herbisid triazinlerinin hazirlanmasina mahsus usul
AR200357A1 (es) Procedimiento de preparacion de nuevos derivados de la isoindolina
SE421693B (sv) Forfarande for framstellning av n-substituerade 1-amino-3-fenoxi-propanoler-(2)
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
AR209281A1 (es) Procedimiento de preparacion de derivados de ciclopropilfenilpirrolidina
AR203196A1 (es) Procedimiento para la preparacion de derivados de imidazol-5-carboxamidoxima
SE409325B (sv) Forfarande for framstellning av kinazolinonderivat
SE406086B (sv) Forfarande for framstellning av cyklisk-dikarboximido-substituerade fosfonotioater
NO146597C (no) Fremgangsmaate for fremstilling av 6-metylentetracykliner